Literature DB >> 1575310

Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients.

A W Hemming1, C H Scudamore, C R Shackleton, M Pudek, S R Erb.   

Abstract

Twenty-two cirrhotic patients who underwent hepatic resection from July 1989 to March 1991 at Vancouver General Hospital were analyzed prospectively in order to determine whether there was any preoperative evaluation of liver function that would help identify those patients who would not survive hepatic resection. Patients were analyzed on the basis of age, type of resection, and a variety of so-called standard liver function tests. In addition, all patients were evaluated preoperatively with an indocyanine green (ICG) clearance test, a relatively new test that we attempted to evaluate in terms of its role in hepatic resection in cirrhotic patients. Parametric statistical evaluation used included Student's t-test and multivariate regression, as well as discriminate analysis. The nonparametric evaluation used was the Wilcoxon rank sum test. Overall, the 30-day mortality rate was 18%, with those patients who did not survive resection having a significantly lower ICG clearance than those who underwent successful resection (p less than 0.0001). No other liver function test was useful in determining the outcome of resection. Similarly, neither age nor type of resection appeared to influence outcome. Use of discriminate analysis (p = 0.0029) allowed the identification of a cutoff point for ICG clearance below which hepatic resection should not be attempted.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575310     DOI: 10.1016/0002-9610(92)90400-l

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  58 in total

Review 1.  Liver resection for cancer.

Authors:  R W Parks; O J Garden
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Indocyanine green elimination test in orthotopic liver recipients.

Authors:  T Tsubono; S Todo; N Jabbour; A Mizoe; V Warty; A J Demetris; T E Starzl
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

3.  The Predictive Value of Indocyanine Green Clearance in Future Liver Remnant for Posthepatectomy Liver Failure Following Hepatectomy with Extrahepatic Bile Duct Resection.

Authors:  Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Masato Nagino
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

Review 4.  Defining Post Hepatectomy Liver Insufficiency: Where do We stand?

Authors:  Kelly Lafaro; Stefan Buettner; Hadia Maqsood; Doris Wagner; Fabio Bagante; Gaya Spolverato; Li Xu; Ihab Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-06-11       Impact factor: 3.452

Review 5.  Post-hepatectomy liver failure in patients with colorectal liver metastases.

Authors:  Masato Narita; Elie Oussoultzoglou; Philippe Bachellier; Daniel Jaeck; Shinji Uemoto
Journal:  Surg Today       Date:  2015-01-29       Impact factor: 2.549

6.  Normal liver tissue change after proton beam therapy.

Authors:  Nobuyoshi Fukumitsu; Shinsei Takahashi; Toshiyuki Okumura; Toshiki Ishida; Keiko Nemoto Murofushi; Kayoko Ohnishi; Teruhito Aihara; Hitoshi Ishikawa; Koji Tsuboi; Hideyuki Sakurai
Journal:  Jpn J Radiol       Date:  2018-07-06       Impact factor: 2.374

7.  Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models.

Authors:  Matthew H Stenmark; Yue Cao; Hesheng Wang; Andrew Jackson; Edgar Ben-Josef; Randall K Ten Haken; Theodore S Lawrence; Mary Feng
Journal:  Radiother Oncol       Date:  2014-05-08       Impact factor: 6.280

8.  Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.

Authors:  Catherine Hubert; Christine Sempoux; Yves Humblet; Marc van den Eynde; Francis Zech; Isabelle Leclercq; Jean-François Gigot
Journal:  HPB (Oxford)       Date:  2013-01-18       Impact factor: 3.647

Review 9.  Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.

Authors:  Christopher H Crane; Eugene J Koay
Journal:  Cancer       Date:  2016-03-07       Impact factor: 6.860

10.  Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure.

Authors:  Uta Merle; Olivia Sieg; Wolfgang Stremmel; Jens Encke; Christoph Eisenbach
Journal:  BMC Gastroenterol       Date:  2009-12-03       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.